They reflect findings from FDA inspections of these facilities over the last several months. At the time of each inspection, the FDA issued inspectional observations and exercised oversight of each firm as they
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.54 by 16.67 percent. This is a 46.51 percent increase over earnings of $0.43 per share from the same
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!
Start typing to search
To view TrendSpider's complete data, please log into your TrendSpider account.